News

Press Release

Synthego and bit.bio expand strategic partnership

Partnership to build a platform for the development of safer and more efficient genetic engineering of human cells for cell therapies.

24.08.2023

Published by bit.bio

Partnership to build a platform for the development of safer and more efficient genetic engineering of human cells for cell therapies.

Published by bit.bio

Read now

Press Release

BlueRock Therapeutics and bit.bio announce collaboration

BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery & manufacture of regulatory T cell...

03.08.2023

Published by bit.bio

Read now

Press Release

Foundational US patent secured for bit.bio's opti-ox technology

bit.bio secures foundational United States patent for opti-ox, its cell programming technology that uses genomic safe harbour site...

26.07.2023

Published by bit.bio

Read now

Press Release

Two new disease models for Duchenne muscular dystrophy

bit.bio launches two new human cell disease models to advance discovery and development of treatments for Duchenne muscular dystro...

12.07.2023

Published by bit.bio

Read now

Press Release

bit.bio is industrialising human cell manufacturing

Industrialising human cell manufacturing will unleash the potential of synthetic biology for reproducible research and affordable ...

15.06.2023

Published by bit.bio

Read now

Press Release

bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

Offering will provide robust, standardised tools for research and drug discovery.

23.05.2023

Published by bit.bio

Read now

Press Release

Weslie Janeway - investor, scientist, philanthropist joins bit.bio Board

Weslie Janeway - investor, philanthropist, and scientist - joins bit.bio's Board of Directors.

11.05.2023

Published by bit.bio

Read now

Press Release

Collaborating with Mekonos to advance non-viral cell engineering

This collaboration will combine the Mekonos novel ex vivo delivery platform with bit.bio’s opti-ox precision cellular reprogrammin...

04.05.2023

Published by Mekonos

Read now

Press Release

Silicon Valley Bank statement

Statement from our CFO on the situation concerning SVB.

12.03.2023

Published by bit.bio

Read now

Related pages